{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:52:17Z","timestamp":1790549537476,"version":"4.1.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:p>The secretion of small molecules by the proximal tubules of the kidneys represents a vital homeostatic function for rapidly clearing endogenous solutes and medications from the circulation. After filtration at the glomerulus, renal blood flow is directed through a network of peritubular capillaries, where transporters of the proximal tubules actively secrete putative uremic toxins and hundreds of commonly prescribed drugs into the urine, including protein-bound substances that cannot readily cross the glomerular basement membrane. Despite its central physiologic importance, tubular secretory clearance is rarely measured or even estimated in clinical or research settings. Major barriers to estimating tubular solute clearance include uncertainty regarding optimal endogenous secretory markers and a lack of standardized laboratory assays. The creation of new methods to measure tubular secretion could catalyze advances in kidney disease research and clinical care. Differences in secretory clearance relative to the GFR could help distinguish among the causes of CKD, particularly for disorders that primarily affect the tubulointerstitium. As the primary mechanism by which the kidneys excrete medications, tubular secretory clearance offers promise for improving kidney medication dosing, which is currently exclusively on the basis of filtration. The differing metabolic profiles of retained solutes eliminated by secretion versus glomerular filtration suggest that secretory clearance could uniquely inform uremic toxicity, refine existing measures of residual kidney function, and improve prediction of cardiovascular and kidney disease outcomes. Interdisciplinary research across clinical, translational, and laboratory medicine is needed to bring this often neglected kidney function into the limelight.<\/jats:p>","DOI":"10.2215\/cjn.12001017","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T20:35:18Z","timestamp":1519850118000},"page":"1291-1296","source":"Crossref","is-referenced-by-count":134,"title":["Proximal Tubular Secretory Clearance"],"prefix":"10.2215","volume":"13","author":[{"given":"Ke","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine and"},{"name":"Kidney Research Institute, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Kestenbaum","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine and"},{"name":"Kidney Research Institute, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1096\/fj.11-0602ufm","article-title":"The anglerfish and uremic toxins","volume":"25","author":"Lowenstein","year":"2011","journal-title":"FASEB J"},{"key":"B4-20230813","first-page":"1","article-title":"The mechanism of the elimination of phenolsulphonephthalein by the kidney\u2014a proof of secretion by the convoluted tubules","volume":"34","author":"Marshall","year":"1923","journal-title":"Bull Johns Hopkins Hosp"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1172\/JCI101618","article-title":"The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man","volume":"24","author":"Smith","year":"1945","journal-title":"J Clin Invest"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/299054a0","article-title":"Direct demonstration of fluid secretion by glomerular renal tubules in a marine teleost","volume":"299","author":"Beyenbach","year":"1982","journal-title":"Nature"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd4461","article-title":"What do drug transporters really do?","volume":"14","author":"Nigam","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00424-003-1089-9","article-title":"The SLC22 drug transporter family","volume":"447","author":"Koepsell","year":"2004","journal-title":"Pflugers Arch"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"F811","DOI":"10.1152\/ajprenal.00351.2003","article-title":"Kidneys sans glomeruli","volume":"286","author":"Beyenbach","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11095-006-9181-4","article-title":"Organic anion transporters of the SLC22 family: Biopharmaceutical, physiological, and pathological roles","volume":"24","author":"Rizwan","year":"2007","journal-title":"Pharm Res"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"F763","DOI":"10.1152\/ajprenal.00405.2002","article-title":"Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient","volume":"284","author":"Sweet","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1097\/01.ASN.0000143473.64430.AC","article-title":"Contribution of multidrug resistance protein 2 (MRP2\/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter","volume":"15","author":"Smeets","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1681\/ASN.2006030205","article-title":"Identification and functional characterization of a new human kidney-specific H+\/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2","volume":"17","author":"Masuda","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1021\/pr200093w","article-title":"Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1)","volume":"10","author":"Wikoff","year":"2011","journal-title":"J Proteome Res"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1681\/ASN.2015091035","article-title":"Kt\/Vurea and nonurea small solute levels in the hemodialysis study","volume":"27","author":"Meyer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.kint.2016.11.002","article-title":"Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial","volume":"91","author":"Sirich","year":"2017","journal-title":"Kidney Int"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ki.2013.154","article-title":"Numerous protein-bound solutes are cleared by the kidney with high efficiency","volume":"84","author":"Sirich","year":"2013","journal-title":"Kidney Int"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-pharmtox-011112-140317","article-title":"Renal transporters in drug development","volume":"53","author":"Morrissey","year":"2013","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"F867","DOI":"10.1152\/ajprenal.00528.2007","article-title":"Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics","volume":"294","author":"Vallon","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s13318-014-0214-9","article-title":"Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats","volume":"40","author":"Ren","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1523-1755.1999.00721.x","article-title":"The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?","volume":"56","author":"Gilbert","year":"1999","journal-title":"Kidney Int"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/IJNRD.S37883","article-title":"Tubulointerstitial disease in diabetic nephropathy","volume":"7","author":"Tonolo","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"Suppl 2","key":"B25-20230813","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.2337\/dcS15-3006","article-title":"SGLT2 inhibitors and the diabetic kidney","volume":"39","author":"Fioretto","year":"2016","journal-title":"Diabetes Care"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1681\/ASN.2014121193","article-title":"Tubular secretion in CKD","volume":"27","author":"Suchy-Dicey","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/00365518909091539","article-title":"Age dependence of renal function: Clearance of iohexol and p-amino hippurate in healthy males","volume":"49","author":"B\u00e4ck","year":"1989","journal-title":"Scand J Clin Lab Invest"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1681\/ASN.V133798","article-title":"New insights into diuretic use in patients with chronic renal disease","volume":"13","author":"Wilcox","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1186\/cc13015","article-title":"Development and standardization of a furosemide stress test to predict the severity of acute kidney injury","volume":"17","author":"Chawla","year":"2013","journal-title":"Crit Care"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1373\/clinchem.2016.260117","article-title":"Diurnal and long-term variation in plasma concentrations and renal clearances of circulating markers of kidney proximal tubular secretion","volume":"63","author":"Rivara","year":"2017","journal-title":"Clin Chem"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ki.1980.43","article-title":"Ultrastructure and function of cysts from human adult polycystic kidneys","volume":"17","author":"Cuppage","year":"1980","journal-title":"Kidney Int"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"B33-20230813","first-page":"223","article-title":"Decreased filtration fraction during active proliferative lupus nephritis: Relation to disease activity and reversibility of renal function","volume":"22","author":"Kallenberg","year":"1984","journal-title":"Clin Nephrol"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s004670050725","article-title":"Renal function during and after childhood acute poststreptococcal glomerulonephritis","volume":"13","author":"Herthelius","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9343(60)90225-4","article-title":"The pathologic physiology of chronic Bright\u2019s disease. An exposition of the \u201cintact nephron hypothesis\u201d","volume":"28","author":"Bricker","year":"1960","journal-title":"Am J Med"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1152\/ajplegacy.1975.229.3.695","article-title":"Tubular organization and vascular-tubular relations in the dog kidney","volume":"229","author":"Beeuwkes","year":"1975","journal-title":"Am J Physiol"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(12)80312-X","article-title":"Tubulointerstitial changes as a major determinant in the progression of renal damage","volume":"20","author":"Nath","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/cts.12481","article-title":"Does secretory clearance follow glomerular filtration rate in chronic kidney diseases? Reconsidering the intact nephron hypothesis","volume":"10","author":"Chapron","year":"2017","journal-title":"Clin Transl Sci"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e328351f68f","article-title":"Association of tenofovir exposure with kidney disease risk in HIV infection","volume":"26","author":"Scherzer","year":"2012","journal-title":"AIDS"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000042803.28024.92","article-title":"Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells","volume":"14","author":"Townsend","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2215\/CJN.06100710","article-title":"Contribution of residual function to removal of protein-bound solutes in hemodialysis","volume":"6","author":"Marquez","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B42-20230813","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2369-14-268","article-title":"Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: A cross-sectional study","volume":"14","author":"Lin","year":"2013","journal-title":"BMC Nephrol"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.kint.2016.09.052","article-title":"Residual renal function: A paradigm shift","volume":"91","author":"Lowenstein","year":"2017","journal-title":"Kidney Int"},{"key":"B44-20230813","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.2015.52","article-title":"Urinary ammonia and long-term outcomes in chronic kidney disease","volume":"88","author":"Vallet","year":"2015","journal-title":"Kidney Int"},{"key":"B45-20230813","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.2016101151","article-title":"Urine ammonium predicts clinical outcomes in hypertensive kidney disease","volume":"28","author":"Raphael","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B46-20230813","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa043161","article-title":"Cystatin C and the risk of death and cardiovascular events among elderly persons","volume":"352","author":"Shlipak","year":"2005","journal-title":"N Engl J Med"},{"key":"B47-20230813","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-142-7-200504050-00008","article-title":"Cystatin C concentration as a risk factor for heart failure in older adults","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/jama.2011.468","article-title":"Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality","volume":"305","author":"Peralta","year":"2011","journal-title":"JAMA"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1093\/ndt\/gfm861","article-title":"Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats","volume":"23","author":"Adijiang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.lfs.2013.05.008","article-title":"Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats","volume":"92","author":"Yisireyili","year":"2013","journal-title":"Life Sci"},{"key":"B51-20230813","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B52-20230813","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ndt\/gfr453","article-title":"Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study","volume":"27","author":"Wu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B53-20230813","first-page":"96","article-title":"Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis","volume":"124","author":"Niwa","year":"1994","journal-title":"J Lab Clin Med"},{"key":"B54-20230813","first-page":"S15","article-title":"Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys","volume":"62","author":"Miyazaki","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"B55-20230813","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201808000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:37:44Z","timestamp":1786369064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201808000-00029"}},"subtitle":["A Neglected Partner of Kidney Function"],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.12001017","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]}}}